Omicron Is Here. Will We Use Our New Covid Drugs Wisely?news2021-12-01T23:11:37+00:00December 1st, 2021|The New York Times|
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panelnews2021-12-01T00:23:13+00:00December 1st, 2021|The New York Times|
U.K. Authorizes Merck’s Antiviral Pill for Covid-19news2021-11-04T17:42:59+00:00November 4th, 2021|The New York Times|
Merck Will Share Formula for Its Covid Pill With Poor Countriesnews2021-10-27T21:07:22+00:00October 27th, 2021|The New York Times|
Gates Foundation Pledges $120 Million to Help Get Merck Covid Pills to Poor Countriesnews2021-10-20T19:15:15+00:00October 20th, 2021|The New York Times|
Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?news2021-10-17T21:15:06+00:00October 17th, 2021|The New York Times|
Merck Asks F.D.A. for Emergency Approval of Covid Pillnews2021-10-12T04:25:38+00:00October 12th, 2021|The New York Times|
